KRAS and colorectal carcinoma: Pathways known to be altered in the pathogenesis of CRC, including WNT and MYC signaling, EMT transition, inflammatory responses (including TNF-α signaling via NFkB), and a suppression of KRAS signaling, were identified in both RSCC and LSCC.